Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Hexter Joshua sold 30,000 Oramed Pharmaceuticals Inc. shares (Form 4)
Traded Oct 1, 2026 · Filed Oct 2, 2026
On Oct 1, 2026, Hexter Joshua (COO & CBO) sold 30,000 Oramed Pharmaceuticals Inc. shares at US$4.51 for US$135K under a trading plan, leaving 1,328,130 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$4.51
- Value
- US$135K
- Holding after
- 1,328,130 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- COO & CBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Sale | 30,000 | US$4.51 | 1,328,130 | Direct |
Source
Related
- Oramed Pharmaceuticals Inc.
- Hexter Joshua
- Oramed Pharmaceuticals Inc. shareholders
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Hexter Joshua · Jul 2, 2026
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026
- Form 4 · Gabay Avraham · Sep 25, 2026
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026